New Radiotheranostic Targets Identified for Diagnosis and Treatment of Endometrial Cancer
September 09, 2025
September 09, 2025
RESTON, Virginia, Sept. 9 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:
* * *
New Radiotheranostic Targets Identified for Diagnosis and Treatment of Endometrial Cancer
*
Two molecular targets--human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24)--are highly promising candidates for new nuclear diagnostics and therapeutics for endometrial cancer, accordi . . .
* * *
New Radiotheranostic Targets Identified for Diagnosis and Treatment of Endometrial Cancer
*
Two molecular targets--human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24)--are highly promising candidates for new nuclear diagnostics and therapeutics for endometrial cancer, accordi . . .